Profile data is unavailable for this security.
About the company
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. The Company's development pipeline includes AVERSA Buprenorphine and AVERSA Methylphenidate. The Company is also developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. Its AVERSA Fentanyl is an abuse-deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse-deterrent technology to reduce the abuse and misuse of fentanyl patches. It is also exploring transdermal delivery of proteins and peptides such as exenatide for type 2 diabetes and follicle-stimulating hormone (FSH) for infertility.
- Revenue in USD (TTM)2.09m
- Net income in USD-5.49m
- Incorporated2016
- Employees13.00
- LocationNutriband Inc121 S Orange Ave Ste 1500ORLANDO 32801-3241United StatesUSA
- Phone+1 (407) 377-6695
- Websitehttps://nutriband.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neuroone Medical Technologies Corp | 2.86m | -13.47m | 29.04m | 16.00 | -- | 6.29 | -- | 10.17 | -0.6922 | -0.6922 | 0.1424 | 0.1779 | 0.369 | 1.66 | 8.94 | 178,516.30 | -174.02 | -172.88 | -211.08 | -274.74 | 27.16 | -- | -471.65 | -674.97 | 2.52 | -- | 0.00 | -- | 62.66 | -- | -18.60 | -- | -- | -- |
| BioRegenx Inc | 22.24k | -571.17k | 29.66m | 10.00 | -- | -- | -- | 1,333.43 | -0.0021 | -0.0021 | 0.00008 | -0.0008 | 0.4899 | -- | -- | 2,224.00 | -1,258.22 | -- | -- | -- | 96.85 | -- | -2,568.21 | -- | -- | -13.23 | 66.29 | -- | -47.25 | -- | -629.37 | -- | -- | -- |
| Femasys Inc | 1.07m | -14.25m | 30.89m | 32.00 | -- | 1.64 | -- | 28.81 | -0.9396 | -0.9396 | 0.0697 | 0.8474 | 0.048 | 0.6886 | 12.16 | 33,498.75 | -63.81 | -- | -71.11 | -- | 64.54 | -- | -1,329.07 | -- | 7.37 | -- | 0.2675 | -- | -11.13 | -- | -25.04 | -- | -- | -- |
| Akili Inc | 1.68m | -59.49m | 31.91m | 68.00 | -- | 0.5435 | -- | 19.02 | -0.761 | -0.761 | 0.0215 | 0.747 | 0.0149 | -- | 9.84 | 24,676.47 | -52.90 | -- | -59.98 | -- | 51.19 | -- | -3,545.47 | -- | -- | -27.18 | 0.1817 | -- | 419.50 | -- | -212.48 | -- | -- | -- |
| Harvard Apparatus Regenertv Tchnlgy Inc | 103.00k | -9.02m | 32.21m | 10.00 | -- | 19.07 | -- | 312.71 | -0.6801 | -0.6801 | 0.0077 | 0.118 | 0.0411 | -- | -- | 10,300.00 | -356.80 | -330.30 | -666.79 | -1,524.88 | 76.70 | -- | -8,684.47 | -35,138.84 | 0.7572 | -- | 0.00 | -- | -- | -- | -44.28 | -- | -39.07 | -- |
| Retractable Technologies Inc | 43.60m | -7.24m | 32.48m | 148.00 | -- | 0.3279 | 114.28 | 0.745 | -0.242 | -0.242 | 1.46 | 3.32 | 0.2323 | 1.80 | 5.62 | 294,573.80 | -3.74 | 12.45 | -3.96 | 14.51 | 20.89 | 40.82 | -16.08 | 18.09 | 6.41 | -3.15 | 0.0153 | -- | -54.02 | 5.55 | -249.46 | -- | 17.42 | -- |
| SeaStar Medical Holding Corp | 0.00 | -26.23m | 32.70m | 12.00 | -- | -- | -- | -- | -1.28 | -1.28 | 0.00 | -0.2913 | 0.00 | -- | -- | 0.00 | -800.85 | -- | -- | -- | -- | -- | -- | -- | -- | -26.51 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| Precision Optics Corporation Inc | 19.22m | -1.72m | 34.69m | 84.00 | -- | 3.06 | -- | 1.80 | -0.289 | -0.289 | 3.27 | 1.87 | 1.09 | 4.31 | 5.09 | 228,782.90 | -9.77 | -6.71 | -13.54 | -10.55 | 33.35 | 33.65 | -8.94 | -5.02 | 1.10 | -10.39 | 0.1823 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Inspira Technologies Oxy BHN Ltd | 0.00 | -11.29m | 36.14m | 37.00 | -- | 5.70 | -- | -- | -0.9549 | -0.9549 | 0.00 | 0.3666 | 0.00 | -- | -- | 0.00 | -88.60 | -114.98 | -108.36 | -159.56 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 24.64 | -- | -- | -- |
| Nutriband Inc | 2.09m | -5.49m | 36.97m | 13.00 | -- | 4.64 | -- | 17.73 | -0.6863 | -0.6863 | 0.2622 | 0.7267 | 0.2457 | 6.15 | 15.94 | -- | -64.63 | -55.21 | -72.05 | -66.74 | 41.34 | 33.32 | -263.05 | -315.87 | 0.854 | -82.63 | 0.0312 | -- | 0.2741 | 53.43 | -22.35 | -- | 65.57 | -- |
| iCAD Inc | 17.32m | -7.01m | 37.97m | 67.00 | -- | 1.14 | -- | 2.19 | -0.2742 | -0.1925 | 0.6747 | 1.27 | 0.3719 | 0.8034 | 2.16 | 258,477.60 | -15.06 | -23.94 | -19.23 | -34.14 | 85.37 | 76.96 | -40.48 | -45.02 | 4.26 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
| Co-Diagnostics Inc | 6.81m | -35.33m | 38.14m | 155.00 | -- | 0.4434 | -- | 5.60 | -1.20 | -1.20 | 0.2321 | 2.75 | 0.0624 | 1.20 | 3.63 | 43,948.71 | -32.36 | 5.77 | -33.85 | 6.15 | 38.57 | 82.24 | -518.68 | 10.94 | 10.52 | -- | 0.00 | 0.00 | -80.09 | 179.54 | -148.15 | -- | 101.27 | -- |
| LENSAR Inc | 42.16m | -14.38m | 38.63m | 130.00 | -- | 1.15 | -- | 0.9162 | -1.34 | -1.34 | 3.77 | 4.16 | 0.6723 | 1.54 | 7.65 | 324,338.50 | -22.93 | -30.97 | -28.10 | -36.94 | 50.06 | 51.04 | -34.11 | -52.30 | 2.64 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| electroCore, Inc. | 16.03m | -18.83m | 43.45m | 68.00 | -- | 5.84 | -- | 2.71 | -3.56 | -3.56 | 2.91 | 1.24 | 0.7847 | 1.35 | 28.68 | 235,735.30 | -92.19 | -70.73 | -146.63 | -88.96 | 82.51 | 75.81 | -117.49 | -352.82 | 1.49 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| United Health Products Inc | 0.00 | -2.62m | 44.38m | 6.00 | -- | -- | -- | -- | -0.011 | -0.011 | 0.00 | -0.007 | 0.00 | 0.00 | -- | 0.00 | -826.01 | -6,446.86 | -- | -- | -- | 53.19 | -- | -132,561.20 | 0.0606 | -20.88 | -- | -- | -100.00 | -- | -55.45 | -- | -- | -- |
Data as of May 09 2024. Currency figures normalised to Nutriband Inc's reporting currency: US Dollar USD
2.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 85.22k | 1.09% |
| Geode Capital Management LLCas of 31 Dec 2023 | 58.57k | 0.75% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 17.27k | 0.22% |
| AlphaQ Advisors LLCas of 31 Mar 2024 | 11.62k | 0.15% |
| Western International Securities, Inc.as of 31 Dec 2023 | 10.93k | 0.14% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2023 | 5.83k | 0.07% |
| Tower Research Capital LLCas of 31 Dec 2023 | 3.08k | 0.04% |
| Triad Hybrid Solutions LLCas of 31 Dec 2023 | 1.75k | 0.02% |
| UBS Securities LLCas of 31 Dec 2023 | 800.00 | 0.01% |
| RBC Dominion Securities, Inc.as of 31 Dec 2023 | 86.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
